Perturbations in Factor XIII Resulting
From Activation and Inhibition Conditions Examined by Solution Based
Methods and Detected by MALDI-TOF MS
Sabo, T. M., Brasher, P. B., Maurer, M. C.
Biochemistry 2007, 46, 10089-10101Employing Mutants
to Study Thrombin Residues Responsible for Factor XIII Activation
Peptide Recognition: A Kinetic Study
Isetti, G., Maurer, M. C.
Biochemistry 2007, 46, 2444-2452
Conformational Analysis of y' peptide
(410-427) Interactions with Thrombin Anion Binding Exosite II
Sabo, T. M., Farrell, D. H., Maurer, M. C.
Biochemistry 2006, 45, 7434-45
Characterizing the Specificity of Activated Factor XIII for
Glutamine-Containing Substrate Peptides
Cleary, D. B., Maurer, M. C.
Biochim Biophys Acta 2006, 1764, 1207-17
Probing Interactions Between the
Coagulants Thrombin, Factor XIII, and Fibrin(ogen)
Maurer, M. C., Trumbo, T. A., Isetti,
G., Turner, B. T. Jr.
Archives of Biochemistry and Biophysics 2006, 445,
36-45
Mapping of Factor XIII Solvent Accessibility as a Function of
Activation State Using Chemical Modification Methods
Turner, B. T. Jr, Sabo, T. M., Wilding, D., Maurer, M. C.
Biochemistry 2004, 43, 9755-9765
Thrombin Activity is Unaltered by N-terminal Truncation of Factor
XIII Activation Peptides
Isetti, G., Maurer, M. C.
Biochemistry 2004, 43, 4150-4159Probing Thrombin's Activity to Accommodate a V34F Substitution Within
the Factor XIII Activation Peptide Segment (28-41)
Isetti, G., Maurer, M. C.
J. Peptide Research 2004, 63, 241-252
|